title: BAVC regimen in CR AML patients.
authors.affiliation: Department of Human Biopathology, University La Sapienza, Roma, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Meloni
authors.forename: M
authors.initials: M
authors.lastname: Vignetti
authors.forename: P
authors.initials: P
authors.lastname: De Fabritiis
authors.forename: M C
authors.initials: MC
authors.lastname: Petti
authors.forename: M R
authors.initials: MR
authors.lastname: Pinto
authors.forename: A M
authors.initials: AM
authors.lastname: Testi
authors.forename: M L
authors.initials: ML
authors.lastname: Vegna
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
mesh_terms: D000293:Adolescent; D000328:Adult; D000677:Amsacrine / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000379:methods* / Q000401:mortality; D002330:Carmustine / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D003561:Cytarabine / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007223:Infant; D007558:Italy / Q000453:epidemiology; D015470:Leukemia, Myeloid, Acute / Q000401:mortality / Q000601:surgery*; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D012074:Remission Induction; D015996:Survival Rate; D014182:Transplantation, Autologous
chemical_list: D000677:Amsacrine; D003561:Cytarabine; D005047:Etoposide; D002330:Carmustine